FDA Adds $24.2 Million To Unapproved Drug Initiative Scorecard
This article was originally published in The Tan Sheet
Executive Summary
Two weeks after FDA officials attempted to explain how well the Center for Drug Evaluation and Research's unapproved drug initiative is working, the agency showed how actions often speak louder than words
You may also be interested in...
CDER Enforcement Priorities Include Quality Control, Drug "Criminalization"
FDA's Center for Drug Evaluation and Research will crack down on manufacturers that attempt to "farm out responsibility," firms that fail to meet reporting requirements and the general "criminalization of our drug supply," said Deb Autor, director of the center's compliance office
CDER Enforcement Priorities Include Quality Control, Drug "Criminalization"
FDA's Center for Drug Evaluation and Research will crack down on manufacturers that attempt to "farm out responsibility," firms that fail to meet reporting requirements and the general "criminalization of our drug supply," said Deb Autor, director of the center's compliance office
Citizen Petitions Are No Place To Request Enforcement Action - FDA
Citizen petitions are not the proper forum to prompt FDA to enforcement activity, the agency says